- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Americans Rush to Sign Up for Obamacare Despite Uncertain Future
What we're reading, December 22, 2016: Americans continue to sign up for Obamacare coverage despite Republicans' promise to repeal the law; California is implementing a $3 billion effort to help the state’s neediest individuals; and Zika vaccine shows success.
As Republicans are poised to repeal the Affordable Care Act (ACA), Americans are continuing to sign up in record numbers. The New York Times reported that there has already been a 400,000 increase in new sign-ups over the same time last year, plus hundreds of thousands of people are being auto-enrolled into the same or similar plans as last year. Interestingly, the 5 states with the most sign-ups all voted for President-elect Donald Trump, who has promised to make an ACA repeal one of his first acts.
California is implementing a $3 billion effort to help the state’s neediest individuals. Projects include connecting former inmates with health clinics and social services, getting homeless people in housing, and providing a place for homeless patients to stay after they leave the hospital, reported Kaiser Health News. The aim of the effort is to combine physical care, mental health care, and social services for the most complex and costly patients in California.
In an early-stage study, an experimental Zika vaccine evoked robust responses in human volunteers. According to Reuters, the study’s volunteers had Zika-specific immune responses after treatment with no significant safety concerns after 14 weeks. There are still no approved vaccines or treatments for the virus, which has spread to more than 60 countries and territories.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
